Conditional Protein Alleles Using Knockin Mice and a Chemical Inducer of Dimerization

Molecular Cell

Volumn 12, Issue 6, 2003, Pages 1615-1624

  Stankunas, Kryn ^a   Bayle, J Henri ^a   Gestwicki, Jason E ^a   Lin, Yun Ming ^a,b   Wandless, Thomas J ^a   Crabtree, Gerald R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; C20 METHALLYLRAPAMYCIN; GLYCOGEN SYNTHASE KINASE 3; HYBRID PROTEIN; PROTEIN DERIVATIVE; PROTEIN FKBP12; PROTEIN FRB; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BINDING COMPETITION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DIMERIZATION; EMBRYO; FEMALE; GENE CONTROL; GENE FUNCTION; GENE FUSION; GENETIC CODE; GENETIC STABILITY; KNOCKOUT MOUSE; MALE; METHODOLOGY; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0346156074     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00491-X     Document Type: Article

References (43)

1. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 275:1997;1930-1934.
2. Belshaw P.J., Ho S.N., Crabtree G.R., Schreiber S.L. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc. Natl. Acad. Sci. USA. 93:1996;4604-4607. a.
3. Belshaw P.J., Spencer D.M., Crabtree G.R., Schreiber S.L. Controlling programmed cell death with a cyclophilin-cyclosporin-based chemical inducer of dimerization. Chem. Biol. 3:1996;731-738. b.
4. Bishop A.C., Ubersax J.A., Petsch D.T., Matheos D.P., Gray N.S., Blethrow J., Shimizu E., Tsien J.Z., Schultz P.G., Rose M.D.et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature. 407:2000;395-401.
5. Brown E.J., Albers M.W., Shin T.B., Ichikawa K., Keith C.T., Lane W.S., Schreiber S.L. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 369:1994;756-758.
6. Castellano F., Montcourrier P., Guillemot J.C., Gouin E., Machesky L., Cossart P., Chavrier P. Inducible recruitment of Cdc42 or WASP to a cell-surface receptor triggers actin polymerization and filopodium formation. Curr. Biol. 9:1999;351-360.
7. Chang C.P., Chen L., Crabtree G.R. Sonographic staging of the developmental status of mouse embryos in utero. Genesis. 36:2003;7-11.
8. Chen J., Zheng X.F., Brown E.J., Schreiber S.L. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin- associated protein and characterization of a critical serine residue. Proc. Natl. Acad. Sci. USA. 92:1995;4947-4951.
9. Choi J., Chen J., Schreiber S.L., Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science. 273:1996;239-242.
10. Dajani R., Fraser E., Roe S.M., Young N., Good V., Dale T.C., Pearl L.H. Crystal structure of glycogen synthase kinase 3 β structural basis for phosphate-primed substrate specificity and autoinhibition Cell. 105:2001;721-732.
11. Doble B.W., Woodgett J.R. GSK-3. tricks of the trade for a multi-tasking kinase J. Cell Sci. 116:2003;1175-1186.
12. 2+/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell. 105:2001;863-875.
13. Granger D.K., Cromwell J.W., Chen S.C., Goswitz J.J., Morrow D.T., Beierle F.A., Sehgal S.N., Canafax D.M., Matas A.J. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation. 59:1995;183-186.
14. Harding W.M., Galat A., Uehling D.E., Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 341:1989;758-760.
15. Hartwell L.H., Culotti J., Reid B. Genetic control of the cell-division cycle in yeast. I. Detection of mutants. Proc. Natl. Acad. Sci. USA. 66:1970;352-359.
16. Hentges K.E., Sirry B., Gingeras A.C., Sarbassov D., Sonenberg N., Sabatini D., Peterson A.S. FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse. Proc. Natl. Acad. Sci. USA. 98:2001;13796-13801.
17. Ho S.N., Biggar S.R., Spencer D.M., Schreiber S.L., Crabtree G.R. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature. 382:1996;822-826.
18. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 406:2000;86-90.
19. Holsinger L.J., Spencer D.M., Austin D.J., Schreiber S.L., Crabtree G.R. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sci. USA. 92:1995;9810-9814.
20. Jacinto E., Hall M.N. Tor signalling in bugs, brain and brawn. Nat. Rev. Mol. Cell Biol. 4:2003;117-126.
21. Johnston J.A., Johnson E.S., Waller P.R.H., Varshavsky A. Methotrexate inhibits proteolysis of Dihydrofolate reductase by the N-end rule pathway. J. Biol. Chem. 270:1995;8172-8178.
22. Khavari P.A., Peterson C.L., Tamkun J.W., Mendel D.B., Crabtree G.R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature. 366:1993;170-174.
23. Kuo C.J., Chung J., Fiorentino D.F., Flanagan W.M., Blenis J., Crabtree G.R. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 358:1992;70-73.
24. Levy F., Johnston J.A., Varshavsky A. Analysis of a conditional degradation signal in yeast and mammalian cells. Eur. J. Biochem. 259:1999;244-252.
25. Lewandoski M., Meyers E.N., Martin G.R. Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb. Symp. Quant. Biol. 62:1997;159-168.
26. Liberles S.D., Diver S.T., Austin D.J., Schreiber S.L. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc. Natl. Acad. Sci. USA. 94:1997;7825-7830.
27. Liu J., Farmer J.D. Jr., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
28. McManus M.T., Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3:2002;737-747.
29. Nagy A. Cre recombinase. the universal reagent for genome tailoring Genesis. 26:2000;99-109.
30. Nurse P., Thuriaux P., Nasmyth K. Genetic control of the cell division cycle in the fission yeast Schizosaccharomyces pombe. Mol. Gen. Genet. 146:1976;167-178.
31. Picard D. Posttranslational regulation of proteins by fusions to steroid-binding domains. Methods Enzymol. 327:2000;385-401.
32. Pruschy M.N., Spencer D.M., Kapoor T.M., Miyake H., Crabtree G.R., Schreiber S.L. Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012. Chem. Biol. 1:1994;163-172.
33. Rivera V.M., Clackson T., Natesan S., Pollock S., Amara J.F., Keenan T., Magari S.R., Phillips T., Courage N.L., Cerasoli F. Jr. et al. A humanized system for pharmacologic control of gene expression. Nat. Med. 2:1996;1028-1032.
34. Sabatini D.M., Erdjument-Bromage H., Lui M., Tempst P., Snyder S.H. RAFT1. a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast tors Cell. 78:1994;35-43.
35. Siekierka J.J., Hung S.H.Y., Poe M., Lin C.S., Sigal N.H. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature. 341:1989;755-757.
36. Spencer D.M., Wandless T.J., Schreiber S.L., Crabtree G.R. Controlling signal transduction with synthetic ligands. Science. 262:1993;1019-1024.
37. Spencer D.M., Graef I., Austin D.J., Schreiber S.L., Crabtree G.R. A general strategy for producing conditional alleles of Src-like tyrosine kinases. Proc. Natl. Acad. Sci. USA. 92:1995;9805-9809.
38. Spencer D.M., Belshaw P.J., Chen L., Ho S.N., Randazzo F., Crabtree G.R., Schreiber S.L. Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization. Curr. Biol. 6:1996;839-847.
39. ter Haar E., Coll J.T., Austen D.A., Hsiao H.M., Swenson L., Jain J. Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8:2001;593-596.
40. Thomas K.R., Capecchi M.R. Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature. 346:1990;847-850.
41. Wang H., Shimizu E., Tang Y.P., Cho M., Kyin M., Zuo W., Robinson D.A., Alaimo P.J., Zhang C., Morimoto H.et al. Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain. Proc. Natl. Acad. Sci. USA. 100:2003;4287-4292.
42. Yatscoff R.W., Wang P., Chan K., Hicks D., Zimmerman J. Rapamycin. distribution, pharmacokinetics, and therapeutic range investigations Ther. Drug Monit. 17:1995;666-671.
43. Zhou P., Bogacki R., McReynolds L., Howley P.M. Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins. Mol. Cell. 6:2000;751-756.